AOAC GFA Stakeholder Program Meeting Book (March 17, 2021)

X Demonstration of repeatability and reproducibility: X Interlaboratory study requirements X Ruggedness and lot-to-lot variability X Information transparency: X Antibody and target characterization Strengths, Challenges & Gaps with Current Guidance

X Cross-reactivity description X Calibrator characterization

11

X Method outputs require too much knowledge and interpretation by end users: X Different results from different methods X Variable units , targets, limits, and performance X Ease of access to method information X Relevance of method results to other data (e.g., risk assessment doses) X Can be nearly impossible to compare results from different methods without extensive additional analysis Strengths, Challenges & Gaps with Current Guidance

12